CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...
Mesa, Arizona, United States and 38 other locations
plus valacyclovir in men with localized, intermediate-risk prostate cancer who are planning to receive external beam radiation ther...
Phase 2
Peoria, Arizona, United States and 6 other locations
pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...
Phase 1
Phoenix, Arizona, United States and 34 other locations
The aim for this study is to investigate the ability of 64Cu-SAR-bisPSMA PET/CT to detect recurrence of prostate cancer...
Phase 3
Mesa, Arizona, United States and 27 other locations
1 and Phase 2 study to evaluate the safety and antitumor activity of INV-9956 in adult patients with advanced metastatic Castration Resistant Prostate...
Phase 1, Phase 2
Scottsdale, Arizona, United States and 16 other locations
radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stim...
Phase 3
Phoenix, Arizona, United States and 72 other locations
with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials....
Phase 4
Scottsdale, Arizona, United States and 53 other locations
plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...
Phase 2, Phase 3
Phoenix, Arizona, United States and 112 other locations
with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....
Phase 3
Phoenix, Arizona, United States and 326 other locations
(control) in participants with metastatic Castration Resistant Prostate Cancer (mCRPC) with prior exposure to at least 1 Androgen R...
Phase 2
Casa Grande, Arizona, United States and 49 other locations
Clinical trials
Research sites
Resources
Legal